Mizuho Raises its Price Target on Humana (HUM)

Mizuho has officially increased its price targets for two major healthcare companies. The financial institution raised the price target for Humana (HUM) and simultaneously raised the price target for Molina Healthcare (MOH). These adjustments indicate a revised upward valuation for both entities by the analysts at Mizuho, reflecting a positive shift in the expected market performance and financial outlook for these specific healthcare providers within the current investment landscape and sector analysis.